What's New on the FDA Drugs Site
January 19, 2017
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Nitrous Oxide, Gas (Updated - Currently in Shortage)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
New and Generic Drug Approvals
January 18, 2017
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Aspirin and Dipyridamole ANDA #206739 | Aspirin; Dipyridamole | Capsule, Extended Release; Oral | ORIG-1 | Sandoz Inc | Approved | |
Benlysta BLA #125370 | Belimumab | Injectable; Injection | SUPPL-57 | Human Genome Sciences Inc. | LABELING | Approved |
Clindesse NDA #050793 | Clindamycin Phosphate | Cream; Vaginal | SUPPL-22 | Perrigo Pharma Intl | MANUF (CMC) | Approved |
Imbruvica NDA #205552 | Ibrutinib | Capsule; Oral | SUPPL-16 | Pharmacyclics Inc | EFFICACY | Approved |
Janumet NDA #022044 | Metformin Hydrochloride; Sitagliptin Phosphate | Tablet; Oral | SUPPL-39 | Merck Sharp Dohme | LABELING | Approved |
Janumet NDA #022044 | Metformin Hydrochloride; Sitagliptin Phosphate | Tablet; Oral | SUPPL-40 | Merck Sharp Dohme | LABELING | Approved |
Janumet Xr NDA #202270 | Metformin Hydrochloride; Sitagliptin Phosphate | Tablet, Extended Release; Oral | SUPPL-15 | Merck Sharp Dohme | LABELING | Approved |
Janumet Xr NDA #202270 | Metformin Hydrochloride; Sitagliptin Phosphate | Tablet, Extended Release; Oral | SUPPL-16 | Merck Sharp Dohme | LABELING | Approved |
Januvia NDA #021995 | Sitagliptin Phosphate | Tablet; Oral | SUPPL-38 | Merck Sharp Dohme | LABELING | Approved |
Kombiglyze Xr NDA #200678 | Metformin Hydrochloride; Saxagliptin Hydrochloride | Tablet, Extended Release; Oral | SUPPL-19 | Astrazeneca Ab | LABELING | Approved |
Kombiglyze Xr NDA #200678 | Metformin Hydrochloride; Saxagliptin Hydrochloride | Tablet, Extended Release; Oral | SUPPL-20 | Astrazeneca Ab | LABELING | Approved |
Onglyza NDA #022350 | Saxagliptin Hydrochloride | Tablet; Oral | SUPPL-19 | Astrazeneca Ab | LABELING | Approved |
Quetiapine Fumarate ANDA #206252 | Quetiapine Fumarate | Tablet, Extended Release; Oral | ORIG-1 | Accord Hlthcare Inc | Tentative Approval |
Searching the Orange Book is now faster and easier with our new mobile app!
Download Orange Book Express
Belum ada tanggapan untuk "CDER New January 23, 2016"
Post a Comment